Monte Rosa Therapeutics: Q1 Earnings Snapshot

BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $32 million in its first quarter.

The Boston-based company said it had a loss of 53 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.

The biopharmaceutical company posted revenue of $1.1 million in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GLUE at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up